21 related articles for article (PubMed ID: 37659141)
1. Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance.
Guo L; Li P; Jing Z; Gong Y; Lai K; Fu H; Dong H; Yang Z; Liu Z
J Inorg Biochem; 2024 Jun; 258():112631. PubMed ID: 38843774
[TBL] [Abstract][Full Text] [Related]
2. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors.
Gonçalves J; Amaral JD; Capela R; Perry MJ; Braga C; Gaspar MM; Piedade FM; Bijlsma L; Roig A; Pinto SN; Moreira R; Florindo P; Rodrigues CMP
Cell Death Discov; 2024 May; 10(1):261. PubMed ID: 38806468
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer mechanisms of four novel platinum(II) 4'-substituted-2,2':6',2''-terpyridine complexes.
Liang CJ; Wu RC; Huang XQ; Qin QP; Liang H; Tan MX
Dalton Trans; 2024 Jan; 53(5):2143-2152. PubMed ID: 38189098
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
[TBL] [Abstract][Full Text] [Related]
5. Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells.
Zhou Z; Du LQ; Huang XM; Zhu LG; Wei QC; Qin QP; Bian H
Eur J Med Chem; 2022 Dec; 243():114743. PubMed ID: 36116236
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
8. Antitumor studies evaluation of triphenylphosphine ruthenium complexes with 5,7-dihalo-substituted-8-quinolinoline targeting mitophagy pathways.
Wang ZF; Huang XQ; Wu RC; Xiao Y; Zhang SH
J Inorg Biochem; 2023 Nov; 248():112361. PubMed ID: 37659141
[TBL] [Abstract][Full Text] [Related]
9. Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections.
D'Amato A; Mariconda A; Iacopetta D; Ceramella J; Catalano A; Sinicropi MS; Longo P
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139855
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
